Sign inJoin waitlistJoin the waitlist

Terri Parker

Assistant Medical Director, Smilow Cancer Hospital, North Haven · Yale-New Haven Hospital

Credentials: · · · ·

History

Yale-New Haven Hospital
Present
Smilow Cancer Hospital
Present
Yale-New Haven Hospital · Yale School of Medicine
Present

Hematology and Medical Oncology
Yale University School of Medicine
2009–2012
Hematology and Medical Oncology
Univ of Connecticut Health Center/John Dempsey Hospital
2008–2009
Internal Medicine
Univ of Connecticut Health Center/John Dempsey Hospital
2005–2008
Saint George's University School of Medicine
2001–2005
University of Pittsburgh
1998–2001
University of Pittsburgh
2001

Research

Oral Selinexor-Dexamethasone for Triple-Class Refractory Multiple Myeloma
New England Journal of Medicine · 2019 · 537 citations
Carfilzomib or bortezomib in combination with lenalidomide and dexamethasone for patients with newly diagnosed multiple myeloma without intention for immediate autologous stem-cell…
The Lancet Oncology · 2020 · 228 citations
Early alterations in stem-like/resident T cells, innate and myeloid cells in the bone marrow in preneoplastic gammopathy
JCI Insight · 2019 · 163 citations

Natalia Neparidze
12 papers
Noffar Bar
10 papers
Madhav Dhodapkar
7 papers
Ajay Nooka
6 papers
Sagar Lonial
5 papers
Dan Vogl
4 papers
David Dingli
4 papers
Francine Foss
4 papers
Joshua Richter
4 papers
Kavita Dhodapkar
4 papers
Paul Richardson
4 papers
RC
Robert Cornell
4 papers

Clinical trials

Maintenance Therapy: Lenalidomide Following Bendamustine and Rituximab Induction Therapy for Chronic Lymphocytic Leukemia
Principal investigator · Terminated · Phase 2
Yale University
2012–2013
Comparing Dara-VCD Chemotherapy Plus Stem Cell Transplant to Dara-VCD Chemotherapy Alone for People Who Have Newly Diagnosed AL Amyloidosis
Site PI · Recruiting · Phase 3
SWOG Cancer Research Network
2024–2030